Pinnacle Transplant

Pinnacle Transplant Technologies is a private, commercial-stage company operating as a specialized tissue bank and contract manufacturer in the biologics sector. It provides a broad portfolio of processed human tissue allografts and offers private-label and custom development services to OEM partners. With over a decade of operation, the company has established regulatory credentials and a supply network with tissue recovery organizations, positioning itself as a key player in the musculoskeletal and wound care allograft market. Its business model is service and product-based, generating revenue from the sale of its allografts and contract manufacturing services.

Validated platform for processing, testing, sterilizing, and machining donated human tissue into various allograft forms (structural bone, DBM, soft tissue, amniotic membrane). Includes capabilities for private-label and custom product development for OEM partners.

Pinnacle competes in the fragmented allograft processing market against large, diversified players like MTF Biologics and Medtronic, as well as numerous other regional tissue banks. Its differentiation is based on quality, customer service, and its flexible OEM partnership model. It also faces competition from synthetic bone grafts and emerging cell-based therapies.